Demonstrating robust effects in vitro, these inhibitors also enhanced hematopoiesis and erythropoiesis in immunodeficient NPSG and NCG-X mice and various anemia models,21 including the Rpl11 haploinsufficiency mouse model of DBA. Here, RPL11 is linked to Diamond-Blackfan anemia.